Mydecine Innovations Group

Mydecine Innovations Group operates an innovative products division within the Natural Therapeutics Sector (NST). Mydecine Innovations Group manages several CBD and psilocybin brands derived from cannabis, which design, manufacture, and distribute cutting-edge products. Mydecine Innovations Group further enhances their portfolio through cultivation properties, land assets, and retail spaces.